1、Yan Li, Jiahui Zhang, Boqin Ma, Wenjun Yu, Meixia Xu, Weijing Luan, Qinglong Yu, Li Zhang , Rong Rong#, Yuanlei Fu, Haiqiang Cao. Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease. Int J Pharm 2024, 666: 124786（通许作者） 2、Chao Wang, Yujing Zhang, Shanbo Yang, Lingyu Shi, Rong Rong#, Tingting Zhang, Yudong Wu and Dongming Xing. Design, synthesis, and bioevaluation of 1h-pyrrolo[3,2-c]pyridine derivative as colchicine-binging site inhibitors with potent anticancer activities. J Enzym Inhib Med Ch 2024, Dec;39(1):2302320.（共同通讯作者） 3、Yuanlei Fu, Ying Kong, Xiangping Li, Dongfang Cheng, Yuqian Hou, Yan Li, Tongfang Li, Yani Xiao, Qiuyan Zhang, Rong Rong#. Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy. Drug Deliv, 2023, 30(1): 2171158.（共同通讯作者） 4、Lin Wang, Xiangping Li, Ying Kong, Furong Wang, Qiuyan Zhang, Chao Lin, Rong Rong#. Pharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry. Eur J Pharm Sci, 2022, 173:106162.（共同通讯作者） 5、Qiu Yan Zhang, Qing Long Yu, Wei Jing Luan, Tong Fang Li, Ya Ni Xiao, Li Zhang, Yi Li, Rong Rong#, and Chun Guang Ren. LWJ-M30, a conjugate of DM1 and B6, for the targeted therapy of colorectal cancer with improved therapeutic effects, RSC Adv, 2023, 13: 10840.（共同通讯作者） 6. 荣荣、孔颖、李祥平、徐梅霞、倪玲、栾委静、李亚平。一种测定血浆中阿巴帕肽的LC-MS/MS检测方法。授权公告号CN119044376B 7、李亚平, 李忠，李震，程东方，荣荣，迟永建，李祥平，孔颖。罗替戈汀前药衍生物、其药物组合物及其用途。授权公告号CN 117105906B |
